Results Of A Phase I Dose Escalation Study Of Arq 751 In Adult Subjects With Advanced Solid Tumors With Akt1, 2, 3 Genetic Alterations, Activating Pi3k Mutations, Pten-Null, Or Other Known Actionable Pten Mutations
CANCER RESEARCH（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined